Animal advocates' push against veal led to a decline in calf rennet availability, inadvertently driving the cheese industry to adopt synthetic biology rennet, making it the norm in cheese production today.
Historically, calf-based rennet was the go-to ingredient for cheese-making. However, a significant shift occurred with the decline of veal consumption promoted by animal rights advocates post-1975, led by the momentum from Peter Singer's book "Animal Liberation." The reduced demand for veal inadvertently led to a scarcity of calf-based rennet, spiking its prices.
This scarcity necessitated an alternative, and biotechnology companies like Pfizer stepped in. They innovated by genetically engineering microbes to produce chymosin, the essential coagulating enzyme in rennet. The FDA's approval of Pfizer's fermentation-produced chymosin (FPC) in 1990 was a pivotal moment, allowing the cheese industry to overcome the calf rennet shortage while also reducing costs.
Beyond the inventive aspect, this historical account underlines the importance of economics in the food industry. The story suggests that advancements in food biotechnology can benefit from shifts in the economic landscape of traditional animal products, and that alternatives can gain traction through market forces as much as through technological efficiency.